NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Feb 2, 2017
Insider Transaction Report
Form 4
MOORE CRAIG W
Director
Transactions
- Exercise/Conversion
Common Stock
2017-02-01$14.99/sh+15,272$228,927→ 104,511 total - Tax Payment
Common Stock
2017-02-01$26.72/sh−8,568$228,937→ 95,943 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-02-01−15,272→ 0 totalExercise: $14.99From: 2012-05-24Exp: 2017-05-23→ Common Stock (15,272 underlying)